AbCellera Biologics Inc (ABCL) insider trading
Every open-market stock purchase and sale by AbCellera Biologics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Andrew Booth (CFO) and 1 other bought $494K in the last 90 days, growing their stake 8%.
Last 12 months: insiders bought $1.6M (7 buys) and sold $0 (0 sales). Last close $11.57 on Aug 20, 2026.
Recent ABCL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 18, 2026 | John S. Montalbano (Director) | Bought | $110K |
| Aug 14, 2026 | Andrew Booth (CFO) | Bought | $384K |
| Jun 11, 2026 | Michael R Hayden (Director) | Bought (not open market) | — |
| Jun 11, 2026 | John S. Montalbano (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Stephen Quake (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Andrew Booth (CFO) | Bought (not open market) | — |
| May 14, 2026 | John S. Montalbano (Director) | Bought | $95.4K |
| Feb 27, 2026 | Andrew Booth (CFO) | Bought | $146K |
| Feb 27, 2026 | Thermopylae Holdings Ltd. (10% owner) | Bought | $131K |
| Feb 26, 2026 | Thermopylae Holdings Ltd. (10% owner) | Bought | $580K |
| Jan 1, 2026 | Carl L. G. Hansen (CEO) | Bought (not open market) | — |
| Jan 1, 2026 | Veronique Lecault (CTO) | Bought (not open market) | — |
| Jan 1, 2026 | Tryn Stimart (C-suite exec) | Bought (not open market) | — |
| Jan 1, 2026 | Andrew Booth (CFO) | Bought (not open market) | — |
| Dec 18, 2025 | Thermopylae Holdings Ltd. (10% owner) | Sold (not open market) | — |
| Dec 1, 2025 | Stephen Quake (Director) | Bought (not open market) | — |
| Nov 26, 2025 | John S. Montalbano (Director) | Bought | $178K |
Who's trading ABCL
- John S. Montalbano, Director: bought $384K (3 buys), last Aug 18, 2026
- Andrew Booth, CFO: bought $530K (2 buys), last Aug 14, 2026
- Michael R Hayden, Director: other filings, last Jun 11, 2026
- Stephen Quake, Director: other filings, last Jun 11, 2026
- Thermopylae Holdings Ltd., 10% owner: bought $711K (2 buys), last Feb 27, 2026
- Veronique Lecault, COO: other filings, last Jan 1, 2026
- Tryn Stimart, C-suite exec: other filings, last Jan 1, 2026
- Carl L. G. Hansen, CEO: other filings, last Jan 1, 2026
Get free alerts when an insider at AbCellera Biologics Inc files a new trade →